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Background: Cardiopulmonary exercise testing allows for assessment of cardiac and respiratory limitation, but is
often affected by patient effort. Indices of oxygen kinetics, including the oxygen uptake efﬁciency slope (OUES),
oxygen uptake–work-rate slope (VO2–WR slope) and the heart rate–oxygen uptake slope (HR–VO2 slope) are
relatively effort independent but may be affected by patient characteristics.
The objective of this study is to identify the impact of factors, such as age, gender, body size, respiratory function,
smoking and beta-blockade on these parameters, as well as generate predictive equations.
Methods: 1708 volunteers from the population-based Study of Health in Pomerania underwent an incremental
bicycle exercise protocol. Markers of oxygen kinetics were calculated. Participants with structural heart disease,
echocardiographic or lung function pathology were excluded, leaving 577 males and 625 females. Age, height,
weight, smoking, forced expiratory volume in 1 s (FEV1) and beta-blockers were analysed for their inﬂuencing
power by gender. Quantile regression analysis determined the reference equations for each parameter.
Results: Age, gender, height, weight and FEV1 (but not percent predicted FEV1) are strongly related to OUES.
Participants using beta-blockers and male smokers had signiﬁcantly lower OUES values. VO2–WR slope was
minimally affected by age, gender, weight and FEV1. Gender, height, weight and beta-blocker use, but not FEV1
and smoking status, were related to the HR–VO2 slope whilst age was only related in females.
Conclusions:Markers of oxygen kinetics are differentially affected by patient characteristics. This study provides
normal reference values for these variables thereby facilitating interpretation of oxygen uptake kinetics in health
and disease.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Background
Recently new cardiopulmonary exercise test (CPET) parameters,
beyond peak oxygen uptake (peakVO2) have demonstrated an improved
ability to predict mortality, in various forms of chronic circulatory
(i.e. heart) failure [1–4].
The oxygen uptake efﬁciency slope (OUES) has greater prognostic
power than the established parameters peakVO2 and the minute venti-
lation to carbon dioxide production (VE/VCO2) slope [1]. OUES is the
slope of the relationship between oxygen uptake (VO2) and minute
ventilation logarithmically transformed (log10VE) [5,6]. Little is knownulatory Health, Imperial College
.: +44 2075941093; fax: +44
rron).
land Ltd. This is an open access articlabout the impact of common clinical factors on OUES. Whilst OUES
appears to be a simple ratio, it is, in reality, an absolute change in VO2
during a relative change in ventilation (as this is logarithmically
corrected) and therefore will be dependent on the absolute VO2. OUES
might therefore be related to variables like weight that affect resting
and exercise VO2.
The Study of Health in Pomerania (SHIP) is a large population cohort
study and recently published the inﬂuence of factors such as age,
gender, body size, smoking and beta-blockade on many of the more
commonly used CPET parameters such as peakVO2 [7,8]. A sample of
participants within the SHIP population also provides predictive equa-
tions for a European population, and, unlike previous studies [9–11],
the distribution of data was across both genders and a wide age range.
The objective of the present study is to identify the impact of factors,
such as age, gender, body size, respiratory function, smoking and beta-
blockade, on newer parameters of oxygen kinetics that can easily bee under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
4 A.J. Barron et al. / IJC Metabolic & Endocrine 7 (2015) 3–9calculated from a standard incremental exercise test, aswell as generate
predictive equations. These parameters include the OUES, the slope
of the relationship between oxygen uptake and work-rate (VO2–WR
slope) and the slope of the relationship between heart rate and oxygen
uptake (HR–VO2 slope).
2. Methods
2.1. Study population
SHIP is a population-based project in the north-east of Germany.
Study details are given elsewhere [12,13]. In brief, a sample from
212,157 inhabitants living in the area was selected from the population
registration ofﬁces, where all German inhabitants are registered. A two-
stage cluster sampling method was adopted from the World Health
Organization Monitoring Cardiovascular Disease Project in Augsburg,
Germany. A representative sample, comprising 7008 adults aged
20–79 years with 292 persons of each sex in each of the twelve 5-year
age strata, was drawn. The net sample (without migrated or deceased
people) consisted of 6267 eligible subjects, of whom 4308 individuals
participated in the baseline study of SHIP (SHIP-0). Data collection
started in 1997 and ﬁnished in 2001, and from March 2003 until
July 2006, a 5-year follow-up examination was performed (SHIP-1).
The sample (without migrated, deceased or non-responding people)
then comprised 3300 subjects (1589 males, 1711 females) aged
25–85 years. Of those, 1708 individuals (834 males and 874 females)
volunteered for a standardised progressive incremental cycle exercise
test. All participants gavewritten informed consent. The study conformed
to the principles of the Declaration of Helsinki as reﬂected by an a priori
approval of the Ethics Committee of the University of Greifswald
(Greifswald, Germany).
2.2 . Pre-exercise diagnostics and exclusion criteria
The deﬁnition of cardiopulmonary disorders was based on self-
reported physician's diagnosis, use of speciﬁc medication, electro- or
echocardiographic pathological ﬁndings, and lung function abnormalities
measured by spirometry and body plethysmography [14,15]. Reasons for
exclusion are reported elsewhere [7]. Initial certiﬁcation of all physicians
and technicians involved in the study was awarded after a minimum of
3 months of training. The data collection phase was monitored by a
Data Safety and Monitoring Committee.
Lung function testingwas performed as part of the SHIP protocol, but
only forced expiration in 1 s (FEV1) was used in this analysis to assess
impact on oxygen kinetic parameters.
2.3 . Exercise testing
A symptom-limited, physician supervised exercise test using one
calibrated electromagnetically braked cycle-ergometer (Ergoselect100;
Ergoline, Bitz, Germany) was performed according to a modiﬁed Jones
protocol [9] (stepwise increase in work-rate of 16 W/min, starting
with unloaded cycling). Gas exchange variables were analysed breath-
by-breath using a VIASYS Healthcare system (Oxycon Pro or Rudolph's
mask; VIASYS GmbH, Hoechberg, Germany). Prior to each test, equip-
mentwas calibrated in standard fashion with reference gas and volume
calibration. Each test was preceded by a ≥3 min resting period. Partici-
pants were encouraged to reach maximal exhaustion. All tests were per-
formed according to current guidelines [16,17], with continuous 12-lead
ECG monitoring and blood pressure measurements with a standard cuff
sphygmomanometer. Minute ventilation (VE), tidal volume (VT), VO2
and VCO2 were averaged over 10-second intervals.
Off-line calculations of OUES, VO2–WRslope andHR–VO2 slopewere
conducted using Matlab (Mathworks, Natick, Mass, USA) using only
data points during exercise. OUES was deﬁned as the slope of the re-
gression line of VO2 plotted against log10VE. VO2–WRslopewas deﬁnedas the slope of the regression line of VO2 plotted against work-rate.
HR–VO2 slope was deﬁned as the slope of the regression line of heart
rate plotted against VO2.
For OUES, the current predictive equations were compared to those
previously published [6] using themedianmale and femalewithin each
10-year age group and BMI ≤ 25 vs N25 kg/m2.2.4. Statistical analysis
Age, height, weight and BMI were assessed as the independent con-
tinuous variables using regression analysis with the CPET parameters as
the dependent variables. The cohortwas divided into 5 age ranges and 2
body mass index (BMI) groups for graphical data representation.
ANOVA was used for categorical potential confounders such as gender,
smoking and beta-blocker use.We used quantile regression to construct
median, 5th and 95th percentile predictive equations [18]. Based on the
results of the regression analysis for each parameter individually, age,
gender, height and weight, beta-blocker use, smoking status (graded
as current or non-smoker — former smokers are graded with non-
smokers) and FEV1 could be included as co-variates in the model (in
keeping with the previous reference ranges published for peakVO2,
anaerobic threshold and O2-pulse). Each variable was only added to
the regression equation for each parameter individually following a
signiﬁcant contribution in the univariate analyses. These co-variates
were also included in a multivariate model and the beta co-efﬁcients
calculated to show the impact of each co-variate on the model.
A p-value of b0.05 was considered signiﬁcant throughout.2.5. Results
Characteristics of study participants are shown in Table 1. There were
1203 participants following clinical exclusions, and one further
participant's exercise data was non-interpretable. Age range was 25–
84 years (males) and 25–80 years (females, n = 625).
Beta-blocker use is speciﬁcally indicated within the tables, however
other anti-hypertensive agents were also used including ACE inhibitors
or angiotensin-receptor blockers (13% of participants), calcium channel
blockers (6%), diuretics (6%), alpha-blockers for hypertension (1%) and
other agents (2%).2.6. Confounding factors on cardiopulmonary exercise testing
The impact of gender, age and BMI is shown in Table 2.
Gender was a determinant of OUES (R2 = 0.38, p b 0.0001) and
HR–VO2 slope (R2 = 0.30, p b 0.0001), with a weaker interaction with
VO2–WR slope (R2 = 0.04, p b 0.0001). Further determinants were
assessed for males and females separately. The relationships between
determinants and parameters are shown in Table 3.
In both males and females, age was strongly inversely related to
OUES. The VO2–WR slopewas onlyweakly, though signiﬁcantly, related
to age; in males this relationship is positive and inverse in females. The
HR–VO2 slope had a weak, albeit signiﬁcant, relation to age in females
only.
Height had a strong, positive relationship to OUES in males and
females. The VO2–WR slope was not related to height. The HR–VO2
slope was weakly, inversely related to height in both genders. Weight
was strongly positively related to OUES. The VO2–WR slope wasweakly
related to weight in both genders. The HR–VO2 slope was strongly, in-
versely related to weight in males and females. Importantly BMI did
not relate as strongly to any of the 3 parameters as height and weight
as co-variates, and the addition of BMI to a simple model of height
and weight did not increase the predictive power of the model (i.e. no
change in R2) suggesting that height and weight, but not BMI should
be used in the more complex regression models.
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5A.J. Barron et al. / IJC Metabolic & Endocrine 7 (2015) 3–9FEV1 was strongly related to OUES and less strongly to the VO2–WR
slope, howeverwhen percentage of predicted FEV1was used thesewere
only weakly related in males and not in females.
OUES was signiﬁcantly lower in males and females taking beta-
blockers (p b 0.001). However beta-blocker use increased with age,
which may explain this difference. Only in the age group of over 65 did
beta-blocker use signiﬁcantly decrease OUES. The VO2–WR slope was
not different in people who took beta-blockers and those that didn't.
The HR–VO2 slope was lower (mean = 0.041) in people taking beta-
blockers than in those who didn't (mean = 0.047). There appeared to
be amore noticeable effect on females (mean=0.055 versus 0.046) com-
pared to males (mean = 0.038 versus 0.032).
Smoking did not relate to VO2–WR slope or the HR–VO2 slope, and
had aweak inverse relationshipwithOUES inmales and aweak positive
relationship in females.
2.7 . Reference distribution
The effect of age, gender, height, weight, beta-blocker use, current
smoking, and FEV1 on thepredictive equations for these threeparameters
is shown in Table 4.
3. Discussion
Here we demonstrate, for three novel CPET parameters, the inﬂu-
ence of common variables, as well as a set of contemporary predictive
equations.
Understanding the impact of individual characteristics on parameters
is important when interpreting the results, rather than using a “one-size
ﬁts all” approach. Gender, age, height and weight are variables known or
measured in all subjects, and are expected to inﬂuence CPET parameters,
however we can see from these results that their impact is variable. The
parameters here described focus on oxygen kinetics, and as such may
tell us more about the heart's role in gas exchange rather than the
lungs'. This is supported by the inﬂuence of beta-blockade on most of
these parameters, with the relative lack of inﬂuence from percentage of
predicted FEV1 and smoking.
Understanding the impact of variables on CPET parameters al-
lows the generation of predictive equations, which are necessary in
order to establish boundaries of normality for patients. Previous pre-
dictive equations should be revisited as populations change. As CPET
availability has grown, the number of commonly reported parameters
has also expanded. In many cases predictive values are either based
on small studies or on studies where participants recruited may not
necessarily be representative of the whole population. It is expected
that over 50% of patients will have values below average, therefore a
measure of the spread of normality is more important than a measure
of the average. Quantile regression allows the calculation of the 5th
and 95th percentileswithout any effect from signiﬁcant outliers beyond
these boundaries.
3.1 . Oxygen uptake efﬁciency slope
OUES is accepted as a largely effort-independent parameter [5].
Therefore in patients who stop prematurely the OUES may remain
applicable to diagnosing the extent of cardiorespiratory limitation. It
has excellent intra-test and test–retest reliability [6,19], and can dis-
criminate severity and prognosis in heart failure patients [1,20,21].
In our study, gender, age, height and weight inﬂuenced OUES, with
lower values in females, and older, shorter, less heavy individuals. This
can be explained by total oxygen uptakewhich, unlike a relative change
in ventilation (i.e. logarithmically corrected), is dependent on the mass
of metabolising tissue. The use of beta-blockers also signiﬁcantly
lowered OUES, although after correction for age this relationship only
persisted in the oldest group of patients (on average patients taking
beta-blockers were 13 years older). FEV1 was strongly related to OUES,
Table 2
Median values (5th, 95th percentiles) for the 3 CPET parameters. Shown for males and females in the 5 age categories and by weight (as divided into 2 categories — normal
weight BMI ≤ 25 kg/m2 and overweight BMI N 25 kg/m2).
Age OUES VO2–WR slope HR–VO2 slope
Males 25–34 2841 (1861, 3675) 10.2 (8.1, 11.6) 0.041 (0.03, 0.057)
Normal weight 35–44 2665 (1770, 4330) 10.1 (7.1, 11.1) 0.043 (0.029, 0.057)
45–54 2524 (1703, 3255) 9.9 (8.8, 11.1) 0.041 (0.026, 0.061)
55–64 2391 (1758, 3565) 9.9 (9, 11.4) 0.042 (0.034, 0.061)
N65 2249 (1478, 3172) 9.9 (4.8, 11.1) 0.043 (0.027, 0.07)
Overweight 25–34 3094 (2380, 4304) 10.4 (8.7, 12) 0.035 (0.025, 0.049)
35–44 2951 (2160, 3963) 10.2 (8.5, 11.6) 0.036 (0.024, 0.049)
45–54 2764 (1909, 4019) 10 (8.3, 11.7) 0.034 (0.022, 0.054)
55–64 2520 (1862, 3833) 9.9 (8.1, 11.3) 0.037 (0.022, 0.054)
N65 2322 (1534, 2971) 10.1 (7.5, 11.5) 0.035 (0.02, 0.052)
Females
Normal weight 25–34 1958 (1505, 2907) 9.3 (8.2, 11.3) 0.058 (0.04, 0.084)
35–44 1908 (1266, 2672) 9.3 (7.4, 10.5) 0.058 (0.038, 0.082)
45–54 1823 (1236, 2431) 9.2 (7.4, 11.3) 0.062 (0.043, 0.092)
55–64 1620 (1166, 2211) 9.5 (7.7, 11.3) 0.059 (0.04, 0.08)
N65 1594 (1209, 2060) 10 (7.5, 11.7) 0.053 (0.035, 0.074)
Overweight 25–34 2090 (1516, 2965) 9.5 (8.3, 10.4) 0.05 (0.031, 0.07)
35–44 2152 (1642, 3058) 9.4 (7.9, 10.9) 0.049 (0.033, 0.075)
45–54 2065 (1403, 2680) 9.4 (7.6, 11.4) 0.053 (0.028, 0.075)
55–64 1814 (1294, 2515) 9.7 (7.9, 11.2) 0.048 (0.024, 0.071)
N65 1571 (1101, 2232) 10.1 (7.4, 12.2) 0.046 (0.028, 0.077)
6 A.J. Barron et al. / IJC Metabolic & Endocrine 7 (2015) 3–9however this is largely due to the very strong relationship FEV1 has with
height and age, such that once corrected for these, FEV1 was no longer
strongly associated. Smoking displays a weak, albeit signiﬁcant, relation-
ship with OUES, which is different in direction between males and fe-
males. Although these reach signiﬁcance, the small R2 value indicates
that the magnitude of inﬂuence is very small, i.e. unlikely to be clinically
relevant. These observations suggest that OUES may be largely indepen-
dent of respiratory function. However within healthy individuals the
lungs are almost never the limiting organ [22,23], andbecauseweexclud-
ed participants with signiﬁcant respiratory abnormalities, even those
with the worst respiratory function retained within the analysis may
still have signiﬁcant redundancy within the lungs to allow for normalTable 3
Relationship between patient characteristics and three cardiopulmonary exercise test parame
independent determinant (age, height, weight, bodymass index (BMI), FEV1, beta-blocker use (
A p b 0.05 indicates statistical signiﬁcance. The R2 value is calculated using linear regression a
preceding (−) indicate an inverse relationship (i.e. an increase in themagnitude of a continuous
for example with beta-blockers, also causes a reduction in the parameter). Signiﬁcant co-varia
efﬁcient within this model indicated.
A OUES VO2–WR slope
Determinant Strength of
relationship (R2)
p-value Beta co-efﬁcient Strength of
relationship (R2)
Age (years) (−)0.17 b0.001 −12.0 (−)0.02
Height (cm) 0.18 b0.001 +8.8 0.00
Weight (kg) 0.12 b0.001 +11.2 0.01
BMI (kg/m2) 0.02 b0.001 0.01
FEV1 (L) 0.22 b0.001 +161.0 0.03
% FEV1 (%) 0.01 0.037 0.01
BB (yes/no) (−)0.01 0.010 −112.7 0.00
Smoker (yes/no) (−)0.01 0.011 −253.5 0.00
B OUES VO2–WR slope
Determinant Strength of
relationship (R2)
p-value Beta co-efﬁcient Strength of
relationship (R2)
Age (years) (−)0.12 b0.001 −9.9 0.02
Height (cm) 0.14 b0.001 +12.5 0.00
Weight (kg) 0.10 b0.001 +9.7 0.01
BMI (kg/m2) 0.03 b0.001 0.01
FEV1 (L) 0.12 b0.001 +3.3 0.01
% FEV1 (%) 0.00 0.54 0.00
BB (yes/no) (−)0.01 0.004 −127.6 0.00
Smoker (yes/no) 0.01 0.006 +1.2 0.00oxygen uptake. Overall we show a strong relationship between the inde-
pendent variables age, height andweight and themeasured OUES, whilst
the other described variables are of limited relevance.
The established adult predictive equations for OUES have two signif-
icant limitations [6]. Firstly the patients were all older (the youngest is
53 years). As the effect of age on OUES was extrapolated from this
data itmay not be applicable for younger patients. Secondly calculations
for the average, rather than reference ranges, are shown. We therefore
feel that our current predictive equations supersede these. The differ-
ence between Hollenberg's equation [6] and the current study's can be
seen graphically in Fig. 1. Unsurprisingly these previous equations
appear to over-predict the average in younger patients.ters. Table A) males and B) females. The R2 value indicates the rough contribution of the
BB) and current smoking status) to the variability of the three dependent CPET parameters.
nalysis (for continuous variables) or ANOVA (for categorical variables). R2 values with a
determinant causes a reduction in theCPET parameter, or thepresence of thedeterminant,
tes on univariate analysis were added to a multivariate model with the resulting beta co-
HR–VO2 slope
p-value Beta co-efﬁcient Strength of
relationship (R2)
p-value Beta co-efﬁcient
0.001 −0.006 0.00 0.66 −0.00007
0.77 (−)0.06 b0.001 −0.00007
0.046 +0.005 (−)0.23 b0.001 −0.00033
0.032 (−)0.17 b0.001
b0.001 +0.156 0.01 0.031 −0.00067
0.003 0.00 0.48
0.36 (−)0.02 0.003 −0.00442
0.86 0.00 0.48
HR–VO2 slope
p-value Beta co-efﬁcient Strength of
relationship (R2)
p-value Beta co-efﬁcient
0.001 +0.007 (−)0.02 b0.001 −0.00006
0.37 (−)0.02 b0.001 −0.00031
0.015 +0.008 (−)0.21 b0.001 −0.00045
0.003 (−)0.17 b0.001
0.003 −0.135 0.01 0.054 −0.00303
0.19 0.01 0.012
0.90 (−)0.02 b0.001 −0.00457
0.17 0.00 0.43
Table 4
Reference ranges predictive equations for three CPET parameters. A subject's predicted average (50th percentile) and range of normality (5th and 95thpercentiles) are calculatedusing age
(A) in years, height (H) in cm, weight (W) in kg, and FEV1 (f) in L. Beta blocker intake (bb) is coded as ‘0’ for no and ‘1’ for yes. Current smoking (cs) is coded as ‘0’ for no and ‘1’ for yes.
Parameter Percentile Value Equation
Females
OUES 5th 1272.9 −727− 6.98A + 11.82H + 6.56 W− 47.65bb− 10.65cs + 15.29f
50th 1876.3 −182.4− 8.89A + 10.12H + 10.51W− 117.65bb− 21.45cs + 40.31f
95th 2613.6 36.5− 18.47A + 15.55H + 12.63W− 317.24bb− 91.98cs + 13.47f
VO2–WR slope 5th 7.66 7.28− 0.01A + 0.02 W− 0.04f
50th 9.47 8.82 + 0.01A + 0.01W− 0.1f
95th 11.3 10.61 + 0.02A + 0.01W− 0.23f
HR–VO2 slope 5th 0.0320 0.0897− 0.0001A− 0.0002H− 0.0004 W− 0.0021bb + 0.0027f
50th 0.0544 0.1327− 0.0001A− 0.0003H− 0.0004 W− 0.0042bb + 0.0027f
95th 0.0796 0.2279 + 0.0001A -0.0008H-0.0005 W− 0.01bb + 0.0038f
Males
OUES 5th 1783.5 54.7− 9.82A + 4.42H + 11.74 W− 227bb− 169cs + 180.72f
50th 2703.5 907.7− 11.51A + 5.67H + 8.62W− 49.99bb− 214.53cs + 172.97f
95th 3951.4 −2380− 13.97A + 34.48H + 9.54W− 251.11bb− 523.24cs−0.47f
VO2–WR slope 5th 8.06 9.31− 0.02A− 0.01W + 0.17f
50th 10.06 9.63− 0.01A + 0.01W + 0.07f
95th 11.47 9.98− 0.003A + 0.01W+ 0.17f
HR–VO2 slope 5th 0.0236 0.0686− 0.0001A− 0.0001H− 0.0002 W− 0.0016bb + 0.0004f
50th 0.0368 0.0743− 0.0001A− 0.0003W− 0.0039bb− 0.0006f
95th 0.0548 0.0795− 0.0001A + 0.00023H− 0.0005 W− 0.002bb− 0.0051f
Fig. 1. A comparison of oxygen uptake efﬁciency slope (OUES) predictive equations. We
compare our current equation to those from a previously accepted reference range for
OUES, for A) males and B) females with relation to age and subdivided according to
body mass index (BMI) groups BMI ≤ 25 kg/m2, BMI N 25 kg/m2. The
median participant within each age decile had their predicted OUES calculated using
both references ranges. The lines represent the regression slope of these median subjects
only and for the Hollenberg equation use the body surface area and age.
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The linear slope of work-rate against VO2 is felt to reﬂect aerobic
work efﬁciency, relating to oxygen delivery and utilisation at themuscle
[24]. It is thus believed to be primarily inﬂuenced by cardiac rather than
respiratory function. What is interesting about this parameter is its
relative independence from gender, age and weight where the magni-
tude of inﬂuence is small despite statistical signiﬁcance.
Previous studies identiﬁed almost identical average values of
10 mL/min/W in healthy subjects with a standard deviation of
0.7–1.0 mL/min/W [10,25]. In patients with heart failure, peripheral
vascular disease and myopathies a reduced slope occurs. In contrast,
extremely ﬁt cyclists have been found to have an increased slope of
11.5 mL/min/W [26]. These studies however have been small or limited
to male gender; accurate conﬁdence intervals will therefore be limited
in their applicability. We therefore believe that this new predictive equa-
tion should supersede previous data. In our cohort age barely affects
median predicted values, however there does appear to be widening of
the 95% percentiles of normality with advancing age. BMI has little effect
on the slope, which is consistent with previous studies [10,25].3.3 . Heart rate to oxygen uptake relationship
In the absence of signiﬁcant pulmonary disease there are threemain
components inﬂuencing oxygen uptake: heart rate, stroke volume
(together measured as cardiac output) and oxygen extraction at
the tissue; the interaction of these three can be assessed. Typically
the relationship of VO2/heart rate, the O2-pulse, is used. Given that
for the majority of subjects peak oxygen extraction is believed to
be near equal under standard conditions [27], the O2-pulse is used
largely as a surrogate for stroke volume. However this has a similar
limitation to peakVO2; sub-maximal effort may fail to produce a
true reﬂection of peak exercise stroke volume. An alternative is the
heart rate–VO2 relationship or slope, with the typical response a lin-
ear progression of heart rate and VO2. A comparable parameter
discussed previously in the literature is the heart rate response (HRR)
equal to (HRpeak−HRrest) / (VO2peak−VO2rest). The slope of the regres-
sion line of HR versus VO2 will be very similar but will incorporate all
data points, and we therefore believe will be more robust (resting
values are especially susceptible to variability). Although a value of
50 beats/L as the upper limit of normal for HRR has been proposed,
the authors are unaware of any studies validating a normal range of
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clinical utilities of this parameter. A healthy subject stopping prematurely
through non-cardiac limitation will display a normal slope; both maxi-
mum heart rate and peakVO2 are similarly reduced from predicted max-
ima and thismakes it amore useful parameter than the O2-pulse in these
cases. In patients with heart failure the slope may either be elevated
(when heart rate responses are maintained) or decreased (when there
is associated chronotropic incompetence). The latter is more commonly
seen, especially in the modern era of beta-blockade. Another cause of
an elevated slope is mitochondrial myopathies [28] where HRR values
above 50 beats/L were found, reﬂecting the increased dependency of
oxygen uptake on heart rate to compensate for reduced oxygen extrac-
tion at the muscle.
The results of the present study showmarkedly highermedian values
amongst females compared to males, with minimal impact from ageing.
Generally the slope is reduced in overweight patients (although the inter-
cept of the HR–VO2 relationship is higher, so that, for any given VO2, the
heart rate may actually be higher — results not shown). Certainly within
a female population, a HR–VO2 slope of 0.05 beats/mL (equivalent to a
HRR of 50 beats/L), would be considered a normal ﬁnding based upon
our data.
3.4. Limitations
SHIP employed a standardised protocol that was the same for all
subjects. In clinical practice it is common to adjust the protocol so that
exercise duration might last 8–12 min. Four hundred and three partici-
pants did not achieve 8 min; 258 participants achieved N12 min. It is
established that shorter, more intense exercise protocols may decrease
the VO2–WR slope [24,29]. Therefore we may see a greater range of nor-
mal values for this parameter given the large spread ofmaximumexercise
times.
This study was conducted in a single region. Typical values in other
countries may be different; however for other industrialised countries
they are likely to be similar to our results. It is possible that there is
selection bias; the participants were volunteers, and individuals who
are adverse to physical activity would be less likely to volunteer. How-
ever, participants with subclinical cardiorespiratory disorders and clin-
ical diseases were excluded from the present analysis, and the sample
undergoing exercise testing was comparable to the general SHIP cohort
with the exception of having fewer hypertensive subjects and fewer
smokers [7]. It is possible that by principally using FEV1 to deﬁne respi-
ratory disease we may have included some participants with preserved
FEV1 but early, asymptomatic lung disease. However we used FEV1
because it was felt that this was more likely to be affected than other
spirometric variables in the majority of cases of lung pathology.
With a recruitment age between 25 and 84 these results may not be
applicable for younger individuals. It is likely that maximum exercise
capacity occurs somewhere between 20–35 years of age; when testing
adults aged 18–25, an age of 25 would seem prudent to enter into the
equation, although this has not been validated.
We have only denoted beta-blocker and other anti-hypertensive
agents use as yes/no. Data recorded did not specify dose or type of
beta-blocker which could potentially affect the results but given the
vast range of doses and beta-blockers statistical analysis of the impact
of this on CPET parameters would be complex.
4. Conclusions
Over recent years cardiopulmonary exercise testing is gaining accep-
tance for a multitude of clinical functions. Here we present determi-
nants of CPET parameters and contemporary reference ranges from a
large European cross-sectional population study for three potentially
effort-independent parameters associated with the kinetics of oxygen
uptake. These parameters will be most useful in patients unable to attain
a cardiopulmonary maxima from their test, but also appear to havespeciﬁc clinical diagnostic utilities. Our study reports not only themedian
value but also the lower 95% conﬁdence limit, in order to be maximally
helpful in clinical practice.
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